Funded Health Care Startups in Denmark
Among the 17 most recent Denmark health care rounds, Orbis Medicines stands out with a disclosed $93M on 2025-01-06, which dwarfs the rest of the disclosed…
Among the 17 most recent Denmark health care rounds, Orbis Medicines stands out with a disclosed $93M on 2025-01-06, which dwarfs the rest of the disclosed amounts in the table (the next-largest disclosed figure is $13M on 2025-05-05 for Dawn Health). Disclosed round sizes also show a wide spread, from Brain+ at $10K on 2023-09-20 up to $93M, with several “undisclosed” entries breaking the pattern of disclosed amounts (TetraKit Technologies on 2025-02-17 and Miiskin on 2025-01-23 are examples).
Geographically, nearly all companies are in the Copenhagen metro area (Copenhagen, Frederiksberg, Kongens Lyngby, Hillerød, and Hørsholm), with the non-metro concentration being Aarhus via Cercare Medical (2025-02-19). Temporally, this slice runs from 2020-08-11 (Practio) to 2025-06-17 (Droplet IV), and the clustering around early 2025 is visible: four rounds in February 2025 (Cercare Medical 2025-02-19, TetraKit Technologies 2025-02-17, and others around late February/early February) sit alongside the late-2024 cluster (e.g., Cessatech 2024-08-12, Scandinavian Biolabs 2024-09-18).
Most recent rounds
17 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Denmark health care list, and how much bigger is it than the next disclosed amount?
Orbis Medicines’ disclosed $93M round dated 2025-01-06 is the standout outlier. The next-largest disclosed figure is Dawn Health’s $13M on 2025-05-05, so Orbis’s disclosed amount is far larger than everything else shown with a disclosed size.
Are the rounds time-clustered near the top of the list, or spread evenly across years?
The range spans 2020-08-11 (Practio) through 2025-06-17 (Droplet IV), but recent years carry most of the visibility in this slice. Early-2025 entries include Cercare Medical ($8M on 2025-02-19), TetraKit Technologies (undisclosed on 2025-02-17), and Dawn Health ($13M on 2025-05-05), while late-2024 includes Cessatech ($730K on 2024-08-12) and Scandinavian Biolabs ($4M on 2024-09-18).
How concentrated is location, and is any city outside Copenhagen-area locations meaningfully represented?
Copenhagen-area addresses dominate: Copenhagen appears repeatedly (e.g., Dawn Health on 2025-05-05 at Copenhagen; CathVision $9M on 2023-07-18 at Copenhagen), and nearby municipalities also recur (Frederiksberg for Woba at $3M on 2023-09-01; Kongens Lyngby for Droplet IV at $2M on 2025-06-17). Aarhus shows up via Cercare Medical (2025-02-19, $8M) and is the clearest non–Copenhagen-area node in these 17 rows.
What stage and disclosure mix looks most common here, considering both “Series Unknown” and disclosed amounts?
“Series Unknown” appears frequently alongside undisclosed figures, including TetraKit Technologies (undisclosed, dated 2025-02-17) and Rokoko Care (undisclosed, dated 2024-06-12). The only clearly labeled large-stage rounds visible include Orbis Medicines at Series A with $93M (2025-01-06) and Levvel Health ApS at Pre-Seed with $2M (2021-08-01), indicating that labeled stages are less consistent than “Series Unknown” in this slice.
Which entries are biggest low-end outliers in disclosed size, and what does that say about the distribution?
Brain+ shows an extreme low disclosed amount of $10K on 2023-09-20, sitting at the bottom of the disclosed amounts in the table, while Orbis Medicines is at $93M on 2025-01-06. Between those ends, disclosed rounds include mid-single-digit and sub-$10M figures such as Woba ($3M on 2023-09-01) and Cercare Medical ($8M on 2025-02-19), with multiple “undisclosed” rounds (e.g., Miiskin on 2025-01-23) preventing a single smooth distribution.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.